Skip to content

R&B FARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

R&B FARMA

BE 0809.126.191
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€92,414
2024 · €80,782+€11,632
Equity
€298,751
2024 · €222,937+€75,814
Cash
€156,633
2024 · €97,507+€59,126
Balance sheet total
€521,346
2024 · €445,888+€75,457

Largest movements

2024 to 2025
Assets
  • Cash +€59,126

    up €59,126 (+60.6%), from €97,507 to €156,633

    mainly Net result for the year (+€92,414) and Tax, wage and social debts (+€23,324)

  • Current investments +€30,629

    up €30,629 (+77.6%), from €39,490 to €70,119

  • Receivables after one year +€15,000

    up €15,000 (+50.0%), from €30,000 to €45,000

    of which Trade receivables: +€45,000

  • Tangible fixed assets -€14,204

    down €14,204 (-15.3%), from €92,650 to €78,446

    of which Land and buildings: -€14,000

  • Deferred charges and accrued income -€7,005

    down €7,005 (-37.5%), from €18,672 to €11,667

Equity and liabilities
  • Reserves +€75,814

    up €75,814 (+34.3%), from €220,937 to €296,751

  • Trade debts -€36,707

    down €36,707 (-28.8%), from €127,552 to €90,845

  • Tax, wage and social debts +€23,324

    up €23,324 (+139%), from €16,827 to €40,151

    of which Taxes: +€19,124

  • Current portion of long-term debt +€17,228

    up €17,228 (+131%), from €13,103 to €30,331

  • Other debts +€15,605

    up €15,605 (+105%), from €14,805 to €30,410

Income statement
  • Gross operating margin +€34,257

    up €34,257 (+24.5%), from €139,883 to €174,140

  • Financial charges +€19,005

    up €19,005 (+284%), from €6,700 to €25,704

  • Taxes +€5,347

    up €5,347 (+16.0%), from €33,463 to €38,810

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €80,782
Gross operating margin +€34,257
Depreciation +€250
Other operating charges +€434
Financial income +€1,041
Financial charges -€19,005
Taxes -€5,347
Result 2025 €92,414
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€105,914
Investment -€33,668
Financing -€13,120
Cash 2024 €97,507
Net result for the year +€92,414
Depreciation +€17,243
Receivables after one year -€15,000
Stocks and contracts +€3,466
Receivables within one year +€4,622
Deferred charges and accrued income +€7,005
Trade debts -€36,707
Tax, wage and social debts +€23,324
Advances received -€4,253
Other debts +€15,605
Accrued charges and deferred income -€1,805
Investment in fixed assets (net) -€3,039
Current investments -€30,629
Debts after one year -€13,749
Current portion of long-term debt +€17,228
Contributions, distributions and other -€16,600
Cash 2025 €156,633
brings cash intakes cash out
Every line side by side 50 lines
Line Code 2024 2025 Change %
Total assets 20/58 €445,888 €521,346 +€75,457 +16.9%
Fixed assets 21/28 €95,150 €80,946 -€14,204 -14.9%
Tangible fixed assets 22/27 €92,650 €78,446 -€14,204 -15.3%
Land and buildings 22 €82,147 €68,147 -€14,000 -17.0%
Plant, machinery and equipment 23 €3,599 €4,411 +€812 +22.6%
Furniture and vehicles 24 €4,404 €3,388 -€1,016 -23.1%
Other tangible fixed assets 26 €2,500 €2,500 = 0.0%
Financial fixed assets 28 €2,500 €2,500 = 0.0%
Current assets 29/58 €350,738 €440,400 +€89,661 +25.6%
Amounts receivable after more than one year 29 €30,000 €45,000 +€15,000 +50.0%
Trade receivables 290 - €45,000 +€45,000
Other amounts receivable 291 €30,000 - -€30,000
Stocks and contracts in progress 3 €79,337 €75,871 -€3,466 -4.4%
Stocks 30/36 €79,337 €75,871 -€3,466 -4.4%
Amounts receivable within one year 40/41 €85,732 €81,110 -€4,622 -5.4%
Trade receivables 40 €85,571 €81,046 -€4,525 -5.3%
Other amounts receivable 41 €160 €63 -€97 -60.6%
Current investments 50/53 €39,490 €70,119 +€30,629 +77.6%
Cash at bank and in hand 54/58 €97,507 €156,633 +€59,126 +60.6%
Deferred charges and accrued income 490/1 €18,672 €11,667 -€7,005 -37.5%
Total equity and liabilities 10/49 €445,888 €521,346 +€75,457 +16.9%
Equity 10/15 €222,937 €298,751 +€75,814 +34.0%
Contributions 10/11 €2,000 €2,000 = 0.0%
Reserves 13 €220,937 €296,751 +€75,814 +34.3%
Distributable reserves 133 €220,937 €296,751 +€75,814 +34.3%
Amounts payable 17/49 €222,952 €222,595 -€357 -0.2%
Amounts payable after more than one year 17 €44,606 €30,857 -€13,749 -30.8%
Financial debts 170/4 €44,606 €30,857 -€13,749 -30.8%
Amounts payable within one year 42/48 €176,541 €191,738 +€15,197 +8.6%
Current portion of amounts payable after more than one year 42 €13,103 €30,331 +€17,228 +131%
Trade debts 44 €127,552 €90,845 -€36,707 -28.8%
Suppliers 440/4 €127,552 €90,845 -€36,707 -28.8%
Advances received on contracts in progress 46 €4,253 - -€4,253
Taxes, remuneration and social security 45 €16,827 €40,151 +€23,324 +139%
Taxes 450/3 €16,827 €35,952 +€19,124 +114%
Remuneration and social security 454/9 - €4,200 +€4,200
Other amounts payable 47/48 €14,805 €30,410 +€15,605 +105%
Accrued charges and deferred income 492/3 €1,805 - -€1,805
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,494 €17,243 -€250 -1.4%
Other operating charges 640/8 €1,941 €1,507 -€434 -22.3%
Gross operating margin 9900 €139,883 €174,140 +€34,257 +24.5%
Operating profit (loss) 9901 €120,448 €155,389 +€34,941 +29.0%
Financial income 75/76B €497 €1,539 +€1,041 +209%
Recurring financial income 75 €497 €1,539 +€1,041 +209%
Financial charges 65/66B €6,700 €25,704 +€19,005 +284%
Recurring financial charges 65 €6,700 €25,704 +€19,005 +284%
Profit (loss) for the period before taxes 9903 €114,246 €131,224 +€16,978 +14.9%
Income taxes 67/77 €33,463 €38,810 +€5,347 +16.0%
Profit (loss) for the period 9904 €80,782 €92,414 +€11,632 +14.4%
Profit (loss) for the period to be appropriated 9905 €80,782 €92,414 +€11,632 +14.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.